Study S001798

A Phase 1, Open-label, Single-arm Study to Investigate the Effect of Retatrutide on Metoprolol Pharmacokinetics in Healthy Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06808802
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 30
Start: 2025-02-03
Primary completion: 2025-04-15
Lead sponsor: Eli Lilly and Company
Conditions: Healthy
Interventions: DRUG:Retatrutide; DRUG:Metoprolol
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:J1I-MC-GZQE

Registered primary outcomes

Pharmacokinetics (PK): Area Under Concentration From Time Zero to Infinity (AUC[0-∞]) of Metoprolol [Day 1 to Day 3]
Pharmacokinetics (PK): AUC (0-∞) of Metoprolol with Retatrutide [Day 9 to Day 11]
PK: Maximum Concentration (Cmax) of Metoprolol [Day 1 to Day 3]
PK: Cmax of Metoprolol with Retatrutide [Day 9 to Day 11]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.